Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
BIAFCompany Name
BIOAFFINITY TECHNOLOGIES INCSector
HealthcareIndustry
Diagnostics & ResearchExchange
NASDAQBIOAFFINITY TECHNOLOGIES INC - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
BIAF - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ -2.14M | $ -11.69M | 0% |
| 3/31/2025 | $ 1.44M | $ -9.74M | -676.56% |
| 12/31/2024 | $ 2.6M | $ -9.04M | -347.41% |
| 9/30/2024 | $ 3.12M | $ -8.45M | -270.62% |
| 6/30/2024 | $ 3.43M | $ -8.74M | -254.47% |
| 3/31/2024 | $ 5.26M | $ -8.37M | -159.14% |
| 12/31/2023 | $ 4.86M | $ -7.94M | -163.47% |
| 9/30/2023 | $ 6.99M | $ -7.24M | -103.5% |
| 6/30/2023 | $ 8.1M | $ -9.87M | -121.84% |
| 3/31/2023 | $ 9.67M | $ -8.21M | -84.97% |
Key Performance Insights, Last 5 Years
- BIOAFFINITY TECHNOLOGIES INC's latest trailing twelve months (TTM) ROE stands at 0%.
- Over the past 5 years, BIOAFFINITY TECHNOLOGIES INC's average ROE has been -225.58%.
- The median ROE for BIOAFFINITY TECHNOLOGIES INC during this period was -161.31%
- BIOAFFINITY TECHNOLOGIES INC reached its highest ROE over the past 5 years at -73.84%.
- The lowest ROE recorded by BIOAFFINITY TECHNOLOGIES INC in the same timeframe -676.56%
BIOAFFINITY TECHNOLOGIES INC's ROE vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROE Benchmarks
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for BIOAFFINITY TECHNOLOGIES INC is calculated as follows: Net Inc. Cmn. [ $ -6.33M ] / Equity [ $ -15.79M ]
(=) ROE [ 0% ] BIAF - Return on Equity, Last 5 years
-676.56%
Minimum
Mar 31, 2025
-73.84%
Maximum
Dec 31, 2022
-225.58%
Average
-161.31%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.63% with a standard deviation of 22.52%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.13K |
|---|---|
| min | -66.24% |
| max | 73.25% |
| average | 1.63% |
| median | 6.53% |
| std | 22.52% |